Examples of Affymax Patent in a sentence
Affymax shall have a period of one hundred twenty (120) days after such notification to or by Affymax, to elect to so enforce such Affymax Patent or Joint Patent.
If at any time Collaborator receives notices from the Japanese Patent Office regarding patent claims or prosecution communications for an Affymax Patent, Collaborator shall send such notices to Affymax within two (2) weeks after receipt of such notices.
Notwithstanding anything to the contrary in this Section 9.5, Affymax shall have the right to withhold consent to any settlement that is reasonably anticipated to have a substantially adverse impact upon any Affymax Patent in the Affymax Territory, or the commercialization, [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
As used in this provision, "Licensed Takeda Technology" means, collectively, (i) any Former Affymax Patent, and (ii) any Takeda Technology made by Takeda's employees, agents, or independent contractors in the course of conducting its activities under this Agreement.
If an Affymax Patent, Joint Patent or Takeda Patent becomes the subject of any proceeding commenced by a Third Party within the Licensed [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Affymax shall have a period of [*] after such notification to or by Affymax, to elect to so enforce such Affymax Patent or Joint Patent.
Office regarding patent claims or prosecution communications for an Affymax Patent, Collaborator shall send such notices to Affymax within two (2) weeks after receipt of such notices.
Notwithstanding anything to the contrary in this Section 9.5, Affymax shall have the right to withhold consent to any settlement that is reasonably anticipated to have a substantially adverse impact upon any Affymax Patent in the Affymax Territory, or the commercialization, manufacture, use, importation, offer for sale or sale of the Product, any Alternative ESA or Bulk Hematide in the Affymax Territory.
On a product by product basis, Collaborator shall pay to Affymax royalties based on the aggregate annual Net Sales of each Product sold in the Licensed Territory at the rate of [ * ] at all times at which a Valid Claim of an Affymax Patent or a Joint Patent covering the composition of matter of such Product (including without limitation the composition of matter of Hematide) exists in the Licensed Territory.